Birte Möhlendick
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Oncology 13
- Pancreatic and Hepatic Oncology Research 5
- Cancer Cells and Metastasis 3
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 8
- Co-authors
- Nikolas H. Stoecklein (14 shared papers)Wolfram Trudo Knoefel (11 shared papers)Winfried Siffert (13 shared papers)Katharina Raba (4 shared papers)Ulf Dittmer (6 shared papers)Ellen Honisch (2 shared papers)Bianca Behrens (2 shared papers)Carina Elsner (4 shared papers)
- Journals
- Frontiers in Genetics (3 papers)Vaccines (3 papers)International Journal of Cancer (3 papers)PLoS ONE (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Birte Möhlendick
32 papers receiving 496 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 162
- Infectious Diseases 155
- Oncology 217
- Neurology 70
- Hepatology 21
Countries citing papers authored by Birte Möhlendick
This map shows the geographic impact of Birte Möhlendick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birte Möhlendick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birte Möhlendick more than expected).
Fields of papers citing papers by Birte Möhlendick
This network shows the impact of papers produced by Birte Möhlendick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birte Möhlendick. The network helps show where Birte Möhlendick may publish in the future.
Co-authors
The 25 scholars most cited alongside Birte Möhlendick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 64 | |
| 2 | 2021 | 59 | |
| 3 | 2021 | 42 | |
| 4 | 2018 | 34 | |
| 5 | 2013 | 33 | |
| 6 | 2022 | 28 | |
| 7 | 2018 | 27 | |
| 8 | 2014 | 25 | |
| 9 | 2017 | 24 | |
| 10 | 2014 | 24 | |
| 11 | 2017 | 16 | |
| 12 | 2022 | 16 | |
| 13 | 2017 | 15 | |
| 14 | 2016 | 15 | |
| 15 | 2022 | 12 | |
| 16 | 2014 | 10 | |
| 17 | 2019 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2024 | 7 | |
| 20 | 2021 | 6 |
About Birte Möhlendick
Birte Möhlendick is a scholar working on Oncology, Infectious Diseases, Cancer Research, Molecular Biology and Epidemiology, having authored 32 papers that have together received 502 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Single-cell and spatial transcriptomics (3 papers), Animal Virus Infections Studies (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (162 citations), Infectious Diseases (155 citations), Oncology (217 citations), Neurology (70 citations) and Hepatology (21 citations). Birte Möhlendick has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Nikolas H. Stoecklein, Wolfram Trudo Knoefel, Winfried Siffert, Katharina Raba, Ulf Dittmer, Ellen Honisch, Bianca Behrens, Carina Elsner, Andreas Kribben and Christoph A. Klein. Their work appears in journals such as Frontiers in Genetics, Vaccines, International Journal of Cancer, PLoS ONE and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.